Pharma

Sun Pharma beat profit expectations for the September quarter, helped by strong domestic demand and growth in innovative drugs. What it means (easy): A shift toward higher-margin innovative medicines helps protect profits when generics face pricing pressure. Positive quarterly beats often lift investor sentiment. Investor takeaway: Look at the mix of generics vs innovative pharmaceutical sales and pipeline readouts. Consistent margin improvement is a green flag.